Intrinsic Value of S&P & Nasdaq Contact Us

NexImmune, Inc. NEXI OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
65/100
4/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$3.33
+3329900%

NexImmune, Inc. (NEXI) has 13 known insider and institutional holders on record. The largest holder is Carmer Scott with 770,923 shares. Other notable holders include Trainer John and OELKE MATHIAS.

NEXI Insider Ownership

Top Holder
Carmer Scott
770,923 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Carmer Scott President and CEO 770,923 2021-02-16
100%
2 Trainer John Chief Financial Officer 186,969 2022-11-25
24%
3 Oelke Mathias Chief Science Officer 134,023 2022-11-25
17%
4 Zeldis Jerome B Executive VP of Research & Dev 80,100 2022-04-07
10%
5 Knight Robert Douglas Chief Medical Officer 48,000 2022-04-07
6%
6 Gandhi Leena Director 44,983 2023-07-07
6%
7 Bertram Timothy Director 44,983 2023-07-07
6%
8 D'angio Paul Director 44,983 2023-07-07
6%
9 Yao Zhengbin Director 44,983 2023-07-07
6%
10 Barer Sol J Director 44,983 2023-07-07
6%
11 Verstandig Grant Director 44,983 2023-07-07
6%
12 Roemer Alan S. Director 3,992 2023-11-22
1%
13 Jones Kristi President and CEO 1 2024-06-13
0%

No ownership data available for NEXI.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message